Schiffelers R M, Storm G, Bakker-Woudenberg I A
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Int J Pharm. 2001 Feb 19;214(1-2):103-5. doi: 10.1016/s0378-5173(00)00643-8.
Sterically stabilized liposomes are able to localize selectively at sites of infection, potentially permitting targeted drug delivery. Up to now, the majority of studies investigating therapeutic efficacy of liposomes have been conducted in animals with an intact host defense infected with high antibiotic-susceptible bacteria. In the present study, the therapeutic efficacy of gentamicin encapsulated in sterically stabilized liposomes, alone or in combination with the free drug was studied in rats with intact host defense as well as leukopenic rats. Rats were inoculated with a high gentamicin-susceptible or low-gentamicin susceptible Klebsiella pneumoniae in the left lung, resulting in an acute unilateral pneumonia. Survival rates demonstrate the valuable therapeutic properties of the liposome-encapsulated drug in these clinically relevant animal models.
空间稳定脂质体能够选择性地定位于感染部位,从而有可能实现靶向给药。到目前为止,大多数研究脂质体治疗效果的实验都是在宿主防御系统完整且感染高抗生素敏感性细菌的动物身上进行的。在本研究中,我们研究了包裹在空间稳定脂质体中的庆大霉素单独使用或与游离药物联合使用时,对宿主防御系统完整的大鼠以及白细胞减少大鼠的治疗效果。给大鼠左肺接种高庆大霉素敏感性或低庆大霉素敏感性的肺炎克雷伯菌,导致急性单侧肺炎。存活率证明了在这些临床相关动物模型中脂质体包裹药物具有重要的治疗特性。